. Author manuscript; available in PMC: 2011 Apr 1.

Published in final edited form as: Med Sci Sports Exerc. 2010 Apr;42(4):739–744. doi: 10.1249/MSS.0b013e3181bcab6c

Table 3.

Cardiac output, heart rate and stroke volume, immediately prior to exercise and during maximal exercise following short-term consumption of placebo and epigallocatechin-3-gallate (n=11).

		Immediately Prior to Exercise	During Maximal Exercise

Cardiac Output	Placebo	7.8 ± 0.6	29.6 ± 2.2
(L·min^-1)	EGCG	6.8 ± 0.4	30.2 ± 1.4
Heart Rate	Placebo	77 ± 3	178 ± 3
(beats·min^-1)	EGCG	70 ± 4^*	177 ± 3
Stroke Volume	Placebo	102 ± 9	166 ± 12
(ml)	EGCG	98 ± 7	171 ± 9

Data are mean ± SE. EGCG: Epigallocatechin-3-gallate.

Denotes difference to placebo prior to exercise (P < 0.05)